Bvf I Gp Llc - Net Worth and Insider Trading

Bvf I Gp Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bvf I Gp Llc owns 25 companies in total, including Five Prime Therapeutics Inc () , Eledon Pharmaceuticals Inc () , and XOMA Corp () among others .

Click here to see the complete history of Bvf I Gp Llc’s form 4 insider trades.

Insider Ownership Summary of Bvf I Gp Llc

Ticker Comapny Transaction Date Type of Owner
Five Prime Therapeutics Inc 2020-10-06 10 percent owner
Eledon Pharmaceuticals Inc 2020-10-01 other: See Explanation of Responses
XOMA Corp 2020-03-13 10 percent owner
Merus NV 2020-06-01 other: See Explanation of Responses
Kymera Therapeutics Inc 2021-06-16 other: See Explanation of Responses
Principia Biopharma Inc 2020-08-18 other: See Explanation of Responses
IDEAYA Biosciences Inc 2020-06-18 other: See Explanation of Responses
CTI BioPharma Corp 2020-03-02 10 percent owner
XOMA Corp 2020-03-13 10 percent owner
Cytokinetics Inc 2020-11-12 other: See Explanation of Responses
Infinity Pharmaceuticals Inc 2021-01-22 other: See Explanation of Responses
GlycoMimetics Inc 2020-10-30 other: See Explanation of Responses
CytomX Therapeutics Inc 2020-12-18 other: See Explanation of Responses
Verastem Inc 2022-01-25 other: See Explanation of Responses
Rain Oncology Inc 2021-04-22 other: See Explanation of Responses
Olema Pharmaceuticals inc 2020-11-18 10 percent owner
Cullinan Oncology Inc 2021-12-31 other: See Explanation of Responses
Repare Therapeutics Inc 2021-10-28 other: See Explanation of Responses
MoonLake Immunotherapeutics 2022-04-05 director & 10 percent owner
4D Molecular Therapeutics Inc 2022-06-16 other: See Explanation of Responses
ESSA Pharma Inc 2022-07-11 10 percent owner
Third Harmonic Bio Inc 2022-12-19 other: See Explanation of Responses
Structure Therapeutics Inc 2023-02-03 other: See Explanation of Responses
Pieris Pharmaceuticals Inc 2023-05-11 10 percent owner
POINT Biopharma Global Inc 2023-11-02 other: See Explanation of Responses

Bvf I Gp Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Bvf I Gp Llc Ownership Network

Ownership Network List of Bvf I Gp Llc

No Data

Ownership Network Relation of Bvf I Gp Llc


Bvf I Gp Llc Owned Company Details

What does Five Prime Therapeutics Inc do?

Who are the key executives at Five Prime Therapeutics Inc?

Bvf I Gp Llc is the 10 percent owner of Five Prime Therapeutics Inc. Other key executives at Five Prime Therapeutics Inc include 10 percent owner Biotechnology Value Fund L P , 10 percent owner Bvf Partners L P/il , and 10 percent owner Bvf Inc/il .

Five Prime Therapeutics Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Five Prime Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Five Prime Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Five Prime Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Five Prime Therapeutics Inc Insider Transactions

No Available Data

Bvf I Gp Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Bvf I Gp Llc. You might contact Bvf I Gp Llc via mailing address: 44 Montgomery St., 40th Floor, San Francisco Ca 94104.

Discussions on Bvf I Gp Llc

No discussions yet.